A New President’s Vision for International Pharmacovigilance Mira Harrison-Woolrych FROM THE ISoP 14 January 2020 Pages: 79 - 81
Medical Devices: Definition, Classification, and Regulatory Implications Jeffrey K. AronsonCarl HeneghanRobin E. Ferner Current Opinion 16 December 2019 Pages: 83 - 93
Medical Devices: Classification and Analysis of Faults Leading to Harms Robin E. FernerJeffrey K. Aronson Original Research Article 05 November 2019 Pages: 95 - 102
The Use of Long-Acting Insulin Analogs and the Risk of Colorectal Cancer Among Patients with Type 2 Diabetes: A Population-Based Cohort Study Richeek PradhanHui YinLaurent Azoulay Original Research Article 14 December 2019 Pages: 103 - 110
Occurrences and Outcomes of Immune Checkpoint Inhibitors-Induced Vitiligo in Cancer Patients: A Retrospective Cohort Study Samy BabaiAnne-Laure VoisinHervé Le-Louet Original Research Article 19 October 2019 Pages: 111 - 117
Development and First Use of the Patient’s Qualitative Assessment of Treatment (PQAT) Questionnaire in Type 2 Diabetes Mellitus to Explore Individualised Benefit–Harm of Drugs Received During Clinical Studies Adam GaterMatthew ReaneyAude Roborel de Climens Original Research Article Open access 02 November 2019 Pages: 119 - 134
A Post-Authorization Safety Study of Quetiapine as Antidepressant Treatment in Sweden: Nested Case–Control Analyses of Select Outcomes Johan ReutforsPhilip BrennerLena Brandt Original Research Article Open access 17 December 2019 Pages: 135 - 145
Exposure to Infliximab During Pregnancy: Post-Marketing Experience Anja GeldhofJennifer SlaterDanielle Coppola Original Research Article Open access 01 November 2019 Pages: 147 - 161
Effectiveness of Risk Minimization Measures for Fentanyl Buccal Tablet (FENTORA) in Canada: A Mixed-Methods Evaluation Using Surveys, Medical Chart Records and Web Surveillance Sigal KaplanAurore BergamascoYola Moride Original Research Article 05 November 2019 Pages: 163 - 177
New Discoveries and Updates on Cutaneous Adverse Drug Reactions Presented at the 24th World Congress of Dermatology, Milan, Italy, 2019 Felix L. ChanNeil H. ShearRoni P. Dodiuk-Gad Meeting Report 31 October 2019 Pages: 179 - 187
The Role of Unit-Dose Child-Resistant Packaging in Unintentional Childhood Exposures to Buprenorphine–Naloxone Tablets Christian HamppMaribeth C. LovegroveJana McAninch Research Letter 20 November 2019 Pages: 189 - 191
Comment on “Evaluation of Potential Drug–Drug Interactions in Adults in the Intensive Care Unit: A Systematic Review and Meta-analysis” Nusret UysalElif Keskin-ArslanYusuf Cem Kaplan Letter to the Editor 29 January 2020 Pages: 193 - 193
Authors’ Reply to Uysal and Colleagues’ Comment on: “Evaluation of Potential Drug–Drug Interactions in Adults in the Intensive Care Unit: A Systematic Review and Meta-Analysis” Adrian WongMary Grace FitzmauriceSandra L. Kane-Gill Letter to the Editor 29 January 2020 Pages: 195 - 196